This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A dose ranging study investigating the efficacy an...
Clinical trial

A dose ranging study investigating the efficacy and safety of sublingual immunotherapy tablets of house dust mite allergen extracts in adults with house dust mite-associated allergic asthma

Read time: 1 mins
Last updated:1st May 2013
Assess the effect of one year of treatment with sublingual immunotherapy tablets of house dust mite (HDM) allergen extracts at a daily dosage of 100 IR, 500 IR or 1000 IR as compared to placebo on the Asthma Control Test´┐Ż (ACT) score, in adults with HDM-associated allergic asthma.
Category Value
Study start date 2013-05-01

View full details